Boundless Bio
amplified cancer cells have significantly elevated replication stress amplified amplified a | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
26 of 51
Related slides by other companies
Genprex
Investor Presentation
October 2022
in small cell lung cancer | Genprex
Alkermes
Investor Day
March 2021
immune modulation in oncology based on engineered have pleiotropic effects and can act on every phase of the cancer immunity cycle alkermes is focusing on based therapies designed to increase visibility of tumor cells to immune system increase tumor killing potential of and cells mutation fusion remove suppressive signals in the tumor modern based drugs need a high degree of engineering to reduce side effects improve enhance efficacy natural killer journal of cancer cycle | Alkermes
BioNTech
Results
August 2021
we intend to expand and accelerate our pipeline development through a mix of targeted in licensing strategic collaborations and a ore | BioNTech
AbCellera
Results
May 2023
solving key challenges in developing cell engager cancer treatments controlling how cells are activated only targeting cancer cells ona | AbCellera
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io